Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

被引:285
作者
Dickson, Dennis W. [1 ]
Fujishiro, Hiroshige [1 ]
DelleDonne, Anthony [1 ]
Menke, Joshua [1 ]
Ahmed, Zeshan [1 ]
Klos, Kevin J. [2 ]
Josephs, Keith A. [4 ]
Frigerio, Roberta [4 ]
Burnett, Melinda [4 ]
Parisi, Joseph E. [3 ,4 ]
Ahlskog, J. Eric
机构
[1] Mayo Clin, Neuropathol Lab, Dept Neurosci, Jacksonville, FL 32224 USA
[2] Neurol Associates Tulsa, Tulsa, OK USA
[3] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA
[4] Mayo Clin, Dept Neurol, Rochester, MN USA
关键词
immunohistochemistry; incidental Lewy bodies; heart; Parkinson's disease; striatum; tyrosine hydroxylase;
D O I
10.1007/s00401-008-0345-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lewy bodies, the histologic hallmark of Parkinson's disease (PD), are detected in the brains of about 10% of clinically normal people over the age of 60 years. When Lewy bodies are found in normal individuals, the process is sometimes referred to as incidental Lewy body disease (iLBD). The distribution of Lewy bodies in iLBD is similar to the distribution in PD, but neuronal populations vulnerable to Lewy bodies do not show significant neuronal loss in iLBD. It remains unknown if Lewy bodies in this setting represent pre-symptomatic PD or an age-related change unrelated to PD. To address this question we identified cases of iLBD and used a marker for dopaminergic and noradrenergic neurons, tyrosine hydroxylase (TH), to determine if there were changes similar to those found in PD. TH immunoreactivity in the striatum and the epicardial nerve fibers was decreased in iLBD compared to normal controls, but not to the same extent as in PD. The findings suggest that iLBD is preclinical PD and that the lack of symptoms is due to subthreshold pathology.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 47 条
  • [1] Frequency of bowel movements and the future risk of Parkinson's disease
    Abbott, RD
    Petrovitch, H
    White, LR
    Masaki, KH
    Tanner, CM
    Curb, JD
    Grandinetti, A
    Blanchette, PL
    Popper, JS
    Ross, GW
    [J]. NEUROLOGY, 2001, 57 (03) : 456 - 462
  • [2] ABBOTT RD, 2007, MOV DISORD
  • [3] Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers
    Beach, TG
    Walker, DG
    Sue, LI
    Newell, A
    Adler, CC
    Joyce, JN
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (04) : 329 - 337
  • [4] PERFUSION-FIXATION OF THE HUMAN-BRAIN FOR IMMUNOHISTOCHEMISTRY - COMPARISON WITH IMMERSION-FIXATION
    BEACH, TG
    TAGO, H
    NAGAI, T
    KIMURA, H
    MCGEER, PL
    MCGEER, EG
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 1987, 19 (03) : 183 - 192
  • [5] BEACH TG, 2008, ACTA NEUROPATHOL
  • [6] Neuropathology of older persons without cognitive impairment from two community-based studies
    Bennett, D. A.
    Schneider, J. A.
    Arvanitakis, Z.
    Kelly, J. F.
    Aggarwal, N. T.
    Shah, R. C.
    Wilson, R. S.
    [J]. NEUROLOGY, 2006, 66 (12) : 1837 - 1844
  • [7] Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
    Berendse, HW
    Booij, J
    Francot, CMJE
    Bergmans, PLM
    Hijman, R
    Stoof, JC
    Wolters, EC
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (01) : 34 - 41
  • [8] α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
    Bloch, A
    Probst, A
    Bissig, H
    Adams, H
    Tolnay, M
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (03) : 284 - 295
  • [9] Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease
    Boeve, B. F.
    Dickson, D. W.
    Olson, E. J.
    Shepard, J. W.
    Silber, M. H.
    Ferman, T. J.
    Ahlskog, J. E.
    Benarroch, E. E.
    [J]. SLEEP MEDICINE, 2007, 8 (01) : 60 - 64
  • [10] Booij J, 2001, SYNAPSE, V39, P101, DOI 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.3.CO